Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.47 is 54% below its 5-year average of 7.51, near the low end of its 5-year range (2.25–40.57).
As of the fiscal period ended Tuesday, June 30, 2026. 15.43% below its 12-month average of 4.11.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.47.
QUICK RATIO (ACID-TEST)
3.47
QUICK RATIO (ACID-TEST) AVG TTM
4.11
QUICK RATIO (ACID-TEST) AVG 3Y
4.33
QUICK RATIO (ACID-TEST) AVG 5Y
7.51
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.43%
CURRENT VS 3Y AVG
-19.78%
CURRENT VS 5Y AVG
-53.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 509 covered companies
CURRENT VS SECTOR MEDIAN
+16.22%
vs the sector median at left
Biomea Fusion, Inc.
Market Cap
$92.54M
Quick Ratio (Acid-Test)
3.47
TTM Avg
4.11
3Y Avg
4.33
5Y Avg
7.51
Market Cap
$92.41M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.24
3Y Avg
1.67
5Y Avg
2.90
Market Cap
$88.97M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.63M
Quick Ratio (Acid-Test)
3.30
TTM Avg
5.38
3Y Avg
8.10
5Y Avg
12.75
Market Cap
$88.21M
Quick Ratio (Acid-Test)
2.71
TTM Avg
1.86
3Y Avg
1.80
5Y Avg
2.82
Market Cap
$87.96M
Quick Ratio (Acid-Test)
1.01
TTM Avg
1.14
3Y Avg
1.20
5Y Avg
1.25
Market Cap
$87.88M
Quick Ratio (Acid-Test)
23.40
TTM Avg
7.13
3Y Avg
4.61
5Y Avg
6.59
Market Cap
$99.01M
Quick Ratio (Acid-Test)
8.54
TTM Avg
8.31
3Y Avg
10.99
5Y Avg
13.37
Market Cap
$101.52M
Quick Ratio (Acid-Test)
9.55
TTM Avg
7.84
3Y Avg
7.78
5Y Avg
8.56
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $92.54M | 3.47 | 4.11 | 4.33 | 7.51 |
| electroCore, Inc. (ECOR)vs › | $92.41M | 1.00 | 1.24 | 1.67 | 2.90 |
| Conexeu Sciences Inc. (CNXU)vs › | $88.97M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | 3.30 | 5.38 | 8.10 | 12.75 |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 2.71 | 1.86 | 1.80 | 2.82 |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 1.01 | 1.14 | 1.20 | 1.25 |
| Equillium, Inc. (EQ)vs › | $87.88M | 23.40 | 7.13 | 4.61 | 6.59 |
| Anixa Biosciences, Inc. (ANIX)vs › | $99.01M | 8.54 | 8.31 | 10.99 | 13.37 |
| Korro Bio, Inc. (KRRO)vs › | $101.52M | 9.55 | 7.84 | 7.78 | 8.56 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.60M | 7.99 | 9.12 | 12.06 | 14.25 |
Quick Ratio
3.47
Excludes inventory
Current Ratio
3.47
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.47 |
| 2026-03-31 | 4.98 |
| 2025-12-31 | 5.23 |
| 2025-09-30 | 3.18 |
| 2025-06-30 | 3.68 |
| 2025-03-31 | 2.25 |
| 2024-12-31 | 3.15 |
| 2024-09-30 | 3.39 |
| 2024-06-30 | 4.62 |
| 2024-03-31 | 5.84 |
| 2023-12-31 | 7.84 |
| 2023-09-30 | 12.49 |
| 2023-06-30 | 15.74 |
| 2023-03-31 | 4.74 |
| 2022-12-31 | 6.17 |
| 2022-09-30 | 11.03 |
| 2022-06-30 | 16.46 |
| 2022-03-31 | 20.98 |
| 2021-12-31 | 38.08 |
| 2021-09-30 | 33.88 |
| 2021-06-30 | 40.57 |
| 2021-03-31 | 12.13 |
| 2020-12-31 | 38.43 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
